Drug Profile
Doxorubicin - Kyowa Kirin
Alternative Names: AdriacinLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Kyowa Hakko Kirin
- Developer Kyowa Kirin
- Class Anthracyclines; Antineoplastics; Cytostatic antibiotics; Doxorubicins; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Lymphoma
Most Recent Events
- 08 Feb 2019 Chemical structure information added